Laura Sottosanti
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Italian regional data and oropharyngeal adverse events to drugs and vaccines: insights from a 3-year spontaneous reporting (2022-2024).
Journal: Pharmacological reports : PR
Published: December 29, 2025
Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021).
Journal: Oral diseases
Published: April 16, 2024
Safety Profile of Vitamin D in Italy: An Analysis of Spontaneous Reports of Adverse Reactions Related to Drugs and Food Supplements.
Journal: Journal of clinical medicine
Published: May 26, 2023
Signal management and risk minimization strategy: a case study on obinutuzumab and non-overt disseminated intravascular coagulation.
Journal: Frontiers in drug safety and regulation
Published: March 27, 2023
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System.
Journal: Drug safety
Published: January 23, 2023
Relationship between injection site reactions and different adalimumab formulations. Analysis of the adverse events reported in Italy in the period 2016-2019.
Journal: European review for medical and pharmacological sciences
Published: April 30, 2021
Drug Safety in Geriatric Patients: Current Status and Proposed Way Forward.
Journal: Drug safety
Published: June 06, 2020
Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database.
Journal: Frontiers in pharmacology
Published: May 23, 2019
Safety of Antiplatelet Agents: Analysis of 'Real-World' Data from the Italian National Pharmacovigilance Network.
Journal: Clinical drug investigation
Published: September 01, 2017
Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting System.
Journal: Drug safety
Published: June 07, 2017
Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study.
Journal: Expert opinion on drug safety
Published: November 24, 2016
Last Updated: 09/26/2026